Clinical Nurse Specialist in Weymouth, MA Accepting Medicare

5 Clinical Nurse Specialist nurses found. Showing 1 - 5

Dr. Ivor Pattison, PH.D., P.C., ARNP Clinical Nurse Specialist - Psych/Mental Health, Geropsychiatric Medicare: Not Enrolled in Medicare Practice Location: 169 Libbey Industrial Pkwy, 2nd Floor, Weymouth, MA 02189 Phone: 781-682-1060    Fax: 781-682-1061

Lea Robichaud, Clinical Nurse Specialist - Oncology Medicare: Medicare Enrolled Practice Location: 101 Columbian St, Weymouth, MA 02190 Phone: 781-624-5000

Kathleen A Abruzese, R.N. Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 55 Fogg Rd, Weymouth, MA 02190 Phone: 781-340-4293    Fax: 781-340-3782

Marysarah C Frank, RNCS Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: May Accept Medicare Assignments Practice Location: 169 Libbey Pkwy, S-2, Weymouth, MA 02189 Phone: 781-682-1060

Frances Murphy Araujo, APRN, BC Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 169 Libbey Industrial Pkwy, 2nd Floor, Weymouth, MA 02189 Phone: 781-682-1060    Fax: 781-682-1061

News Archive

Researchers develop and test new MRI coil for preclinical studies

Researchers from ITMO University developed and tested an MRI coil providing high-resolution imaging of the whole body of a mouse.

Drug abuse continues to be a pervasive problem

The University of Michigan's Monitoring the Future study (MTF) - the largest survey on teen drug abuse tracking over 46,000 8th, 10th and 12th graders - underscores that teens' intentional abuse of prescription (Rx) and over-the-counter (OTC) medicines continues to be a cause for concern, with an alarming number of young people abusing medicines they obtain from friends and relatives.

Depression symptoms together with AD pathology could trigger changes in memory and thinking

Increasingly, Alzheimer's disease research has focused on the preclinical stage, when people have biological evidence of AD but no or minimal symptoms, and when interventions might have the potential to prevent future decline of older adults.

Positive results from interim analysis of ongoing Phase 2a study of BCX4208

BioCryst Pharmaceuticals, Inc. announced positive top-line results from a planned interim analysis of its ongoing Phase 2a, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of orally administered BCX4208 in patients with gout.

New microchip separates tumour cells in blood stream

Ikerlan-IK4 and Mondragón Unibertsitatea are taking part in a project initiated by the Spanish National Research Council, CSIC, and which has developed a microchip capable of separating and extracting tumour cells in the blood stream by means of ultrasonic waves. The Foundation General Hospital of the University of Elche, together with researcher Alfredo Carrato, has also collaborated on this project.

Read more Medical News

› Verified 1 days ago